View in EDS HTML Full Text PDF Full Text

Economic Benefit of Aflibercept 8 mg Versus Faricimab for Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the US.

Saved in:
Bibliographic Details
Title: Economic Benefit of Aflibercept 8 mg Versus Faricimab for Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the US.
Authors: Kuznik, Andreas1 (AUTHOR) andreas.kuznik@regeneron.com, Coughlan, Anna2 (AUTHOR), Pinsent, Amy3 (AUTHOR), Toro-Diaz, Hector2 (AUTHOR), Sherman, Steven1 (AUTHOR), Patel, Nimesh4,5,6,7 (AUTHOR)
Source: Ophthalmology & Therapy. Nov2025, Vol. 14 Issue 11, p2863-2875. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 188779223
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Economic Benefit of Aflibercept 8 mg Versus Faricimab for Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the US.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Kuznik%2C+Andreas%22">Kuznik, Andreas</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> andreas.kuznik@regeneron.com</i><br /><searchLink fieldCode="AR" term="%22Coughlan%2C+Anna%22">Coughlan, Anna</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pinsent%2C+Amy%22">Pinsent, Amy</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Toro-Diaz%2C+Hector%22">Toro-Diaz, Hector</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sherman%2C+Steven%22">Sherman, Steven</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Patel%2C+Nimesh%22">Patel, Nimesh</searchLink><relatesTo>4,5,6,7</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Ophthalmology+%26+Therapy%22">Ophthalmology & Therapy</searchLink>. Nov2025, Vol. 14 Issue 11, p2863-2875. 13p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=188779223
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40123-025-01236-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 2863
    Titles:
      – TitleFull: Economic Benefit of Aflibercept 8 mg Versus Faricimab for Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema in the US.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kuznik, Andreas
      – PersonEntity:
          Name:
            NameFull: Coughlan, Anna
      – PersonEntity:
          Name:
            NameFull: Pinsent, Amy
      – PersonEntity:
          Name:
            NameFull: Toro-Diaz, Hector
      – PersonEntity:
          Name:
            NameFull: Sherman, Steven
      – PersonEntity:
          Name:
            NameFull: Patel, Nimesh
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: Nov2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 21938245
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Ophthalmology & Therapy
              Type: main
ResultId 1